Curative Biotechnology, Inc. (CUBT)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -486.58 Thousand | -1.53 Million | -1.6 Million | -190.09 Thousand | -150.00 | -150.00 |
| Net Income | -3.95 Million | -5.6 Million | -5.34 Million | -4.67 Million | 331.95 Thousand | -28.91 Thousand |
| Depreciation & Amortization | 90.01 Thousand | 7956.00 | 6744.00 | 5301.00 | 5301.00 | 5301.00 |
| Deferred income taxes | - | 3800.00 | 166.3 Thousand | 32.13 Thousand | - | - |
| Stock-based compensation | 228.29 Thousand | 298.55 Thousand | 2.88 Million | 4.3 Million | - | - |
| Change in working capital | -46.55 Thousand | 2.74 Million | 549.02 Thousand | 109.13 Thousand | 15.88 Thousand | 14.88 Thousand |
| Other non-cash items | 3.19 Million | 1.03 Million | 124.67 Thousand | 30.61 Thousand | -353.28 Thousand | 8581.00 |
| Investing Cash Flow | -14.04 Thousand | -76.9 Thousand | -21.33 Thousand | -34.3 Thousand | - | - |
| Investments in PPE | -14.04 Thousand | -76.9 Thousand | -21.33 Thousand | -34.3 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -14.04 Thousand | -76.9 Thousand | -14.50 | -34.30 | - | - |
| Financing Cash Flow | 498.35 Thousand | 1 Million | 2.13 Million | 385 Thousand | 150.00 | 150.00 |
| Debt repayment | -35 Thousand | -86.7 Thousand | -50 Thousand | -385 Thousand | -150.00 | -150.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 542.32 Thousand | 268.39 Thousand | 1.57 Million | - | - | - |
| Other Financing Activities | 498.35 Thousand | 819.19 Thousand | 612.02 Thousand | 770 Thousand | 300.00 | - |
| Accounts receivables | - | 25 Thousand | -25 Thousand | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -46.55 Thousand | 2.71 Million | 574.02 Thousand | 109.13 Thousand | 15.88 Thousand | 15.88 Thousand |
| Cash at beginning of period | 58.66 Thousand | 670.26 Thousand | 160.6 Thousand | - | - | - |
| Cash at end of period | 56.4 Thousand | 58.66 Thousand | 670.26 Thousand | 160.6 Thousand | - | - |
| Capital Expenditure | -14.04 Thousand | -76.9 Thousand | -21.33 Thousand | -34.3 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2268.00 | -611.59 Thousand | 509.65 Thousand | 160.6 Thousand | - | - |
| Free Cash Flow | -500.62 Thousand | -1.61 Million | -1.62 Million | -224.39 Thousand | -150.00 | -150.00 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -697.74 Thousand | -899.34 Thousand | -3.95 Million | -2.03 Million | -820.12 Thousand | -131.97 Thousand |
| Depreciation & Amortization | 21.92 Thousand | 26.42 Thousand | 97.51 Thousand | 91.54 Thousand | 1989.00 | 1989.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 228.29 Thousand | - | - | - |
| Change in working capital | 236 Thousand | 508.54 Thousand | 2.29 Million | 1.09 Million | 646.56 Thousand | 11.83 Thousand |
| Other non-cash items | 373.37 Thousand | 209.84 Thousand | 1.26 Million | 969.42 Thousand | 8079.00 | 10.58 Thousand |
| Investing Cash Flow | - | -15 Thousand | -14.04 Thousand | 11.00 | -8445.00 | - |
| Investments in PPE | 1.00 | -15 Thousand | -14.04 Thousand | 11.00 | -8445.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -14.04 Thousand | - | - | - |
| Financing Cash Flow | 421.66 Thousand | 168.95 Thousand | 498.35 Thousand | 89.6 Thousand | 210 Thousand | 15 Thousand |
| Debt repayment | - | - | -35 Thousand | - | - | -15 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 306.04 Thousand | 168.95 Thousand | 542.32 Thousand | 168.57 Thousand | 210 Thousand | - |
| Other Financing Activities | 115.62 Thousand | - | -78.97 Thousand | -78.97 Thousand | - | - |
| Accounts receivables | -125.62 Thousand | 115.62 Thousand | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 361.62 Thousand | 392.92 Thousand | 2.29 Million | 1.09 Million | 646.56 Thousand | 11.83 Thousand |
| Cash at beginning of period | 118.6 Thousand | 56.4 Thousand | 58.66 Thousand | 35.58 Thousand | 1497.00 | 98.03 Thousand |
| Cash at end of period | 304.35 Thousand | 118.6 Thousand | 56.4 Thousand | 56.4 Thousand | 35.58 Thousand | 1497.00 |
| Capital Expenditure | 1.00 | -15 Thousand | -14.04 Thousand | 11.00 | -8445.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 185.74 Thousand | 62.2 Thousand | -2268.00 | 20.81 Thousand | 34.08 Thousand | -96.53 Thousand |
| Free Cash Flow | -235.92 Thousand | -106.75 Thousand | -500.62 Thousand | -68.79 Thousand | -175.91 Thousand | -111.53 Thousand |
BEL
DEVYANI
4019
PBI
HL
SHB-B